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INFLUENZA VIRUS HEMAGGLUTIN IN-SPECIF IC  
CYTOTOXIC  T CELL RESPONSE INDUCED BY 
POLYPEPT IDE PRODUCED IN ESCHERICHIA COLI 
BY AKIO YAMADA,* MARSHA R. ZIESE,* JAMES F. YOUNG,* 
YASUKO K. YAMADA,* AND FRANCIS A. ENNIS* 
From *The Division fInfectious Diseases, the Department of Medicine, the University of 
Massachusetts Medical School, Worcester, Massachusetts 01605, andthe *Molecular Genetics 
Division, Smith, Kline, and French Laboratories, Philadelphia, Pennsylvania 19101 
During the course of influenza A virus infection, two different subsets of 
cytotoxic T lymphocytes (CTL) 1 are induced in mice and in humans. There are 
both subtype-specific CTL responses and responses that are crossreactive among 
the influenza A subtypes; both responses are restricted by class I major histocom- 
patibility complex (MHC) antigens (1-4). These CTL have been shown to play a 
crucial role in the recovery from influenza virus infection (5-8). 
The definition of the viral determinants hat are recognized by these subsets 
of CTL is not complete (for review, see ref. 9). Preparations of hemagglutinin 
(HA) have been reported (10, 11) to stimulate a subtype-specific response. 
Wabuke-Bunoti and Fan (12) reported that the smaller subunit of HA (HA2), 
purified from bromelain-treated virions, induced a weak but significant second- 
ary CTL response, which was subtype-specific. Becht et al. (13), however, failed 
to show the induction of the secondary CTL response using purified HA2 
obtained by the selective digestion of virions with acid protease followed by 
treatment with mild detergent. On the other hand, several CTL clones appar- 
ently recognizing determinant(s) on the internal proteins, such as viral nucleo- 
protein (NP), have been isolated (14). Using a panel of recombinant viruses, 
Townsend and Skehel (14, 15) reported that the gene coding for NP determined 
the specificity of the effector lymphocytes, in that the target cells infected with 
the virus strain sharing only NP gene with the virus used for stimulation could 
be lysed by certain clones of CTL, or CTL generated in bulk cultures and 
stimulated in special ways. For the recognition of the target cells by crossreactive 
CTL, in addition to viral HA (16, 17), more conserved viral proteins, such as 
matrix protein and NP have been postulated to be responsible (9, 18, 19). 
To elucidate which viral proteins are involved in the recognition by MHC- 
restricted CTL, we examined the abilities of several influenza viral polypeptides 
prepared by gene cloning techniques to induce the secondary CTL responses. 
This research was supported by grants from the National Institute of Health, Bethesda, MD, (1RO1- 
A119378) and from the Office of Naval Research (N001-83-K-0357). 
1Abbreviations u ed in this paper: CTL, cytotoxic T lymphocyte; E:T, effector/target; HA, 
hemagglutinin; 1L-2, interleukin 2; MHC, major histocompatibility complex; NP, nucleoprotein; 
SNF, supernatant fluid. 
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664 CYTOTOXIC T CELL RESPONSE TO BIOSYNTHETIC PEPTIDE 
Our  results show that one of them (cl 3 protein), which is a hybrid protein of the 
first 81 amino acids of the viral NS 1 nonstructural protein and the HA2 subunit 
of  viral HA, stimulated H-2-restricted, influenza virus subtype-specif ic secondary 
CTL  in vitro. Furthermore,  immunization of mice with cl 3 protein induced the 
generation of memory  CTL  response in vivo. 
Mater ia ls  and  Methods  
Mice. Male BALB/c mice were purchased from Charles River Breeding Laboratories, 
Inc. (Wilmington, MA), and used at the age of 4-5 wk. 
Virus. Influenza A viruses, A/PR/8 (A/Puerto Rico/8/34 [H1N1]), A/BZ (A/Bra- 
zil/ 11/78 [H 1N 1 ]), A/Chile (a/Chile/I/83 [H 1N 1 ]), A/JAP (A/Japan/305/57 [H2N2]), 
A/BK (A/Bangkok/I/79 [H3N2]), and A/PC (A/Port Chalmers/1/73 [H3N2]), were 
propagated in 9-d-old embryonated chicken eggs. Infected allantoic fluids were harvested 
on day 3 after infection and clarified by low-speed centrifugation. The supernatant fluid 
was divided into small vials and stored at -80°C until use. A/X31 (H3N2), a recombinant 
strain obtained by cross between A/PR/8/34 and A/Hong Kong/1/68 (H3N2) was 
generously provided by Dr. E. D. Kilbourne of the Mount Sinai School of Medicine, New 
York. 
Production of lnfluenza Virus-spec~c Proteins in E. coli. Influenza virus-specific poly- 
peptides were produced in E. coli using the expression system described previously (20- 
22). Briefly, plasmids containing DNA fragments complementary to the viral RNA of 
A/PR/8 virus (23) were manipulated to achieve xpression of the following products: (a) 
the NS1 nonstructural protein; (b) cl 3, the first 81 amino acids of NS1 fused to HA2; (c) 
A13, the first 81 amino acids of NS1 fused to the first 69 amino acids of HA2; (d) c7, the 
entire HA (minus the signal peptide); (e) A7, the HA1 and the first 69 amino acids of 
HA2; and (f)  c36, the HA2 alone. The NS1 protein was purified as described previously 
(22). Unlike the NS1 protein, the HA-containing polypeptides were insoluble when 
produced in E. coli. Therefore, after lysis of the bacteria, two 0.1% deoxycholate 
extractions, and one 1% Triton X- 100 extraction to remove contaminating E. coli proteins, 
the HA-specific proteins were solubilized with 4 M urea (4°C for 30 rain). The urea was 
then removed by dialysis at 4°C. All proteins were stored in 50 mM Tris-I-ICl, pH 8.0, 1 
mM EDTA. The purity of these products was >80%. 
Immunization of Mice. Mice were immunized with ~ 1,000 plaque forming units of the 
virus intranasally without anesthesia. To immunize mice with a polypeptide, the solution 
containing 500 #g/ml of c13 protein was mixed with an equal amount of complete 
Freund's adjuvant, and 0.2 ml of the mixture was inoculated into mice subcutaneously. 3 
wk after the primary injection, mice were given an intraperitoneal booster inoculation of 
50 ug without adjuvant. 
Induction of Secondary CTL In Vitro. Spleens were aseptically removed from mice 
immunized with the virus at least 3 wk before, and were teased through a stainless teel 
mesh. After lysing red blood cells by treatment with ACK lysing buffer (155 mM NH4C1, 
10 mM KHCO3, and 190 mM EDTA), cells were washed and resuspended in RPMI 1640 
medium containing 100 U/ml penicillin and 100 #g/ml streptomycin supplemented with 
10% heat-inactivated fetal bovine serum at a concentration of 2.5-3.0 x I0  6 cells/ml. 
Responder cells were cultured with virus-infected syngeneic spleen cells taken from normal 
mice at a ratio of 10:1, or with various concentrations of peptides at 37°C for 5 d in 5% 
COy. 
CTL Assay. P815 (H-2 d) cells were used as target cells for the standard 5~Cr-release 
assay. Single-cell suspensions of P815 cells were infected with the desired virus at an input 
multiplicity of >10 PFU/cell. Immediately after inoculation of the virus, 250 #Ci of 
Na,~5~CrO4 (New England Nuclear, Boston, MA) was added. After incubation at 37°C for 
90 rain, the target cells were washed twice with RPMI and further incubated at 37°C for 
6 h. 104 ~aCr-labeled target cells were incubated with effector cells at various ratios in a 
96-well, round-bottom icroplate (Linbro, McLean, VA) at 37°C for 4 h. The supernatant 
fluid (SNF) of cultures was harvested by the aid of harvesting frames (Skatron Inc., 
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YAMADA ET AL. 665 
Sterling, VA), and the radioactivities of SNF were counted in a gamma counter (Packard 
Instrument Co. Inc., Downers Grove, IL). Percent specific lysis was calculated as follows: 
percent specific lysis = (experimental release - minimum release) × 100/(maximum 
release - minimum release). Maximum and minimum release were obtained by incubating 
target cells with 10% Renex 30 solution (Ruger Chem. Co., Irvington, NJ) and medium 
alone, respectively. 
Maintenance of CTL in Presence of lnterleukin 2 (IL-2). In vitro-stimulated spleen cell 
cultures were maintained for 3 wk in RPMI 1640 containing 10% FBS, 5 × 10 -5 M 2- 
mercaptoethanol, and either 4% rat (Collaborative Research Inc., Lexington, MA) or 
20% human (Meloy Laboratories Inc., Springfield, VA) IL-2. 
Determination of Precursor Frequencies of CTL. Precursor frequencies of influenza virus- 
specific CTL were determined by a limiting-dilution method (24). Spleen cell suspensions 
diluted to desired concentrations were distributed into round-bottom, 96-well microplates 
(100 #l/well), and cultured with 106 X-irradiated (2,500 rad) syngeneic spleen cells infected 
with A/PR/8 virus in the presence of exogenous IL-2. At least seven dilutions of the cell 
suspension were prepared, and 24 wells were seeded with each dilution. After incubation 
at 37°C for 7 d, each well was assayed for cytotoxicity against A/PR/8 virus-infected 
P815 target cells (2,000 cells/well) directly, or after splitting into two replicas. Estimates 
of the CTL precursor frequency were calculated by an iterative procedure based on 
maximum likelihood analysis described by Fazekas de St. Groth (25). 
Resu l ts  
Induction of Secondary CTL Response by Various Polypeptides. We examined the 
ability o f  various polypeptides to stimulate A /PR/8  v i rus - immune lymphocytes 
to generate a secondary CTL  response in vitro. 2 .5 -3 .0  × 107 immune cells were 
cul tured with various concentrat ions o f  polypeptides o f  A /PR/8  v i rus- infected 
syngeneic lymphocytes at 37°C  for  5 d. Table  I shows that immune spleen cells 
st imulated with A /PR/8  v i rus- infected syngeneic ells were highly cytotoxic to 
A /PR/8  v i rus- infected P815 cells but not to uninfected P815 cells, c 13 protein,  
which is a hybr id peptide between the first 81 amino acids o f  NS1 and HA2,  
st imulated the secondary response in vitro. A l though the level o f  killing by c 13 
TABLE I 
Induction of Secondary CTL In Vitro by E. coli-derived Protein 
Exp. 
Percent specific lysis 
Secondary A/PR/8 Uninfected 
stimulation 
30 10 30 10 
A/PR/8* 62.5 40.5 6.7 2.6 
NS1 0.1 -3.2 4.3 0.0 
C13 19.3 4.0 0.5 -0.5 
A13 --2.5 --4.6 --1.3 0.0 
A7 2.1 --2.0 2.9 --0.9 
None 0.0 2.0 1.9 3.2 
A/PR/8 91.9 89.2 16.4 11.5 
c13 28.6 11.3 -1.2 -1.0 
c36 6.2 -2.5 -2.1 -1.1 
c7 4.4 -3.7 -0.8 -0.8 
Protein concentrations were 5/*g/ml and 12 #g/ml, in exp. 1 and 2, respectively. 
E:T (effector/target) ratios were 30:1 and 10:1. 
* A/PR/8 (H 1N 1)-infected syngeneic stimulator ceils. 
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666 CYTOTOX1C T CELL RESPONSE TO BIOSYNTHETIC PEPTIDE 
protein-stimulated cells was lower than that obtained with effector cells induced 
by virus-infected stimulator cells, the induction of CTL response by c 13 protein 
was found to be dose-dependent, and the killing of virus-infected target cells was 
H-2-restricted (not shown). Interestingly, neither c36 protein, which is HA2 
alone, nor c7 protein, which is the entire HA, induced any CTL responses. 
Virus Specificity of Secondary CTL Induced by c13 Protein. To determine the 
virus specificity of the secondary CTL induced by c13 protein, A/PR/8 virus- 
or A/PC virus-immune spleen cells were stimulated with cl 3 protein and tested 
for their ability to lyse both A/PR/8 virus- and A/PC virus-infected P815 cells. 
As shown in Table II, the effector cells stimulated by A/PR/8 virus- and A/PC 
virus-infected cells lysed both A/PR/8 virus- and A/PC virus-infected target 
cells, c13 protein-induced effector cells, however, lysed only A/PR/8 virus- 
infected target cells. We then tested cl 3 protein-induced ffector cells for their 
cytotoxicity on P815 cells infected with other HI and H3 viruses. Although 
these effector cells lysed all H 1 virus-infected target cells, regardless of the year 
of isolation, they did not iyse H3 virus-infected cells. Target cells infected with 
H2 viruses were not killed by cl 3 protein-induced ffector cells (Fig. 1). These 
results indicate that c13 protein induced an H1 virus subtype-specific CTL 
response. To know whether internal proteins of A/PR/8 virus were involved in 
the recognition by c l 3 protein-induced CTL, their cytotoxicity against A/X31 
(H3N2) virus-infected target cells, which contain the internal proteins derived 
from A/PR/8 virus and the external glycoproteins from H3N2 virus, was 
examined. A/X31 virus-infected cells were not lysed by c13 protein-induced 
CTL, whereas they were lysed by A/PR/8 virus-induced CTL (Fig. 1 b). This 
finding indicates that cl 3 protein-induced CTL recognize viral external glyco- 
proteins. 
Induction of CTL Memory In Vivo by c13 Protein. The observation that c13 
protein was able to stimulate influenza virus-specific secondary CTL response 
in vitro led us to investigate whether this protein has the potential to generate 
memory CTL response in vivo. Mice were immunized with 50 #g of cl 3 protein 
TABLE II 
Virus Specificity of c l 3-induced CTL 
Stimulation Percent specific lysis 
Primary Secondary 
A/PR/8(H 1 N 1) A/PC(H3N2) Uninfected 
30 10 30 10 30 10 
A/PR/8 A/PR/8 80.5 59.4 72.8 55.8 4.2 0.2 
A/PC 77.9 76.1 74.2 59.3 2.3 2.1 
c13 33.2 14.8 -0.4 -0.7 1.7 1.3 
None 1.7 -0.8 0.5 -1.9 -0.9 -1.3 
A/PC A/PR/8 96.0 72.9 74.3 57.5 9.8 1.8 
A/PC 92.3 75.6 85.1 80.0 10.2 3.8 
c13 6.7 1.0 4.3 -5.0 2.6 0.2 
None -2.1 -1.1 -2.5 -3.5 1.2 -0.5 
A/PR/8 virus and A/PC virus were used in this experiment. Spleen cells taken from A/PR/8 virus- 
and A/PC virus-immune mice were stimulated with A/PR/8 virus-infected syngeneic spleen cells or 
with c13 protein (24/~g/ml), then assayed for cytotoxicity at E:T ratios of 30:1 and 10:1. 
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F IGURE 1. Virus specificity of cl 3 protein-induced effector cells. (a) Effector cells obtained 
by stimulation of A/PR/8 virus-immune spleen cells with A/PR/8 virus-infected cell (e) and 
those induced with c 13 protein (O) were tested for their cytotoxicity on P815 cells infected 
with A/PR/8 (H 1N 1), A/BZ (H 1N 1), and A/PC (H3N2) viruses. Normal spleen cells stimulated 
with A/PR/8 virus-infected cells (A), and those induced with cl 3 protein (A) were also tested 
along with immune (I) and normal (I-1) spleen cells cultured without stimulation. (b) A/PR/8 
virus-inamune spleen cells stimulated with A/PR/8 virus-infected spleen cells (e) and c13 
protein (O) were tested on P815 cells infected with A/PR/8 (H1N1), A/BZ (H1N1), A/Chile 
(H 1N 1), A/JAP (H2N2), and A/X31 (H3N2) viruses. 
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668 CYTOTOXIC T CELL RESPONSE TO BIOSYNTHETIC PEPTIDE 
in complete Freund's adjuvant, and were boosted 3 wk later by the intraperito- 
neal inoculation of 50 /~g of c13 protein. 1 wk after the secondary injection, 
spleen cells were obtained and cultured with A /PR/8  virus-infected stimulator 
cells at 37°C for 5 d. As shown in Table III, spleen cells taken from c13 protein-  
immunized mice responded to the secondary stimulation with A /PR/8  virus- 
infected stimulator cells, resulting in the specific killing of A /PR/8  virus-infected 
P815 target cells. This table also shows that these effector cells did not lyse 
A/PC virus-infected target cells, suggesting that the response was virus subtype- 
specific. These effector cells failed to lyse A /PR/8  virus-infected L929 (H-2 k) 
cells (data not shown). 
Cytotoxicity of Cultured CTL Derived from In Vitro Stimulation with c13 Pro- 
tein. We tried to maintain these effector cells in vitro in the presence of 
exogenous IL-2 after the secondary stimulation. The  effector cells obtained by 
stimulation of A /PR/8  virus- immune cells with A /PR/8  virus-infected cells 
showed a high level of  cytotoxicity to A /PR/8  and A/PC virus-infected target 
cells at lower E:T ratios after maintenance for 3 wk (Table IV). c13 protein-  
stimulated A/PR/8  virus- immune cells lysed A/PR/8  virus-infected target cells 
more efficiently than A/PC virus-infected target cells, c13 prote in- immune 
spleen cells stimulated with A /PR/8  virus-infected cells killed A /PR/8  virus- 
infected target cells, but did not kill A/PC virus-infected target cells. These data 
indicate that c 13 protein- induced cytotoxicity was maintained in vitro for a long 
period in the presence of  IL-2 without losing virus-specificity. 
Determination of Precursor Frequency of CTL. These results indicate that c13 
protein has an ability to induce not only secondary CTL  activity in vitro but also 
memory CTL  response in vivo. Therefore,  we attempted to determine the CTL  
precursor frequencies of c13 protein-immune mice. 1 wk after the booster 
inoculation with c l 3 protein, spleen cells were tested for their CTL  precursor 
frequencies by limiting-dilution analysis. The  results are contained in Table V. 
The  frequencies of A /PR/8  virus- and cl 3 prote in- immune spleen cells were 
TABLE III 
Induction of Memory CTL in Mice Immunized with c13 Protein 
Stimulation Percent specific lysis 
Primary Secondary 
A/PR/8 A/PC Uninfected 
30 10 30 10 30 10 
A/PR/8 A/PR/8 68.7 37.7 55.7 30.8 -0.1 0.2 
None 6.8 1.7 4.5 -1.8 0.1 -0.6 
c13 A/PR/8 18.0 5.9 i0.8 -3.9 0.8 -1.4 
None -1.5 i3.0 0.1 i5.3 -1.3 -1.2 
None A/PR/8 3.3 2.1 -3.2 -3.5 -2.7 -2.2 
None 4.3 2.8 -2.1 -3,6 -2.0 i0.1 
BALB/c mice were immunized subcutaneously with 50 ~g of c13 protein emulsified n an equal 
volume of complete Freund's adjuvant and boosted intraperitoneally 3 wk lat r with 50 #g of c l 3 
protein without adjuvant. 1 wk after the booster injection, spleen cells were cultured with A/PR/8 
virus-infected syngeneic spleen cells at 37°C for 5 d. CTL activity was assayed on P815 cells infected 
with A/PR/8 virus and A/PC virus using E:T ratios of 30:1 and 10:1. 
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TABLE IV 
Cytotoxicity ofCTL after Maintenance In Vitro in Presence of lL-2 
669 
Stimulation Percent specific lysis 
Primary Secondary 
A/PR/8 A/PC Uninfected 
10 3 10 3 10 3 
A/PR/8 A/PR/8 73.3 57.5 63.3 50.2 2.4 3.7 
c13 47.6 24.6 17.5 2.9 2.0 1.4 
c13 A/PR/8 26.6 7.2 6.4 -1.5 1.6 -0.6 
None A/PR/8 -3.4 -4.8 -0.3 0.7 2.0 -0.4 
c13 0.8 -3 .0  4.0 -2.1 0.1 -0.8 
Immunization of mice with the virus and cl 3 protein is given in the Materials and Methods. Protein 
concentration used for in vitro stimulation was 12.5 #g/ml. Cytotoxicity was assayed after 3 wk of in 
vitro culture, using E:T ratios of 10:1 and 3:1. 
TABLE V 
Comparison of Precursor Frequencies 
hnmunization Precursor fre- Stimulation by: 95% confidence limit with: quencies (1/f) 
A/PR/8 A/PR/8 8,047 5,710-11,341 
c 13 A/PR/8 50,312 37,140-68,154 
None A/PR/9 Nil 
A/PR/8 A/PR/8 15,111 11,004-20,752 
A/P R/8 c 13 73,177 49,482-108,219 
A/PR/8 None Nil - -  
Precursor frequencies of A/PR/8 virus- and c13 protein-immunized mice were deter- 
mined by the limiting-dilution method (24). The estimates were calculated by solution 
of maximum likelihood equation, as described by Fazekas de St. Groth (25). 
estimated as one in 8,047 and 50,312, respectively. Spleen cells from nonimmune 
mice did not contain detectable precursors. Although the level of precursor 
frequency of c13 protein-immune spleen cells was lower than that of A/PR/8 
virus-immune mice, these results showed that mice immunized with cl 3 protein 
had increased amounts of CTL precursors compared to nonimmune mice. We 
also determined the frequency of CTL precursors in A/PR/8 virus-immune 
spleen cells recognizing c13 protein. The frequency of A/PR/8 virus-immune 
spleen cells reacting with c 13 protein was estimated as 1/73,177, whereas those 
reacting with A/PR/8 virus-infected cells were 1/15,111. To further define the 
virus specificity of c 13 protein-induced effector cells at the clonal level, we made 
two replicas from each plate of limiting-dilution analysis and tested them against 
target cells infected with H1 and H3 virus strains. As shown in Table VI, the 
precursor frequencies of CTL reacting with A/PR/8 virus-infected stimulator 
cells were very close when we tested them against H1 and H3 virus-infected 
target cells. However, the precursor frequency of CTL induced by c13 protein 
was strikingly lower against H3 virus-infected targets than against H1 virus- 
infected targets, indicating that virus specificity observed in bulk cultures (Table 
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670 CYTOTOXIC T CELL RESPONSE TO BIOSYNTHETIC PEPTIDE 
TABLE VI 
Virus Specificity of c l 3 Protein-induced CTL at the Clonal Level 
Exp. Stimulation 
1 PR8 
c13 
2 PR8 
c13 
3 c13 
4 c13 
Precursor frequency ( l / f )  
H1NI H3N2 
19,791 20,813 
14,477-27,057)* (14,904-29,065) 
23,620 233,575 
17,679-31,560) (146,644-372,040) 
21,256 25,813 
15,840-28,524) (18,318-36,375) 
85,699 256,684 
59,164-124,228) (137,692-478,506) 
63,047 290,846 
44,818-88,689) (145,539-581,231 
114,501 Nil 
81,137-161,585) 
A/PR/8 virus-immune spleen cells were cultured in limiting-dilution 
conditions with A/PR/8 virus-infected, syngeneic, X-irradiated spleen 
cells, or with c 13 protein (12.5 #g/ml) in the presence of X-irradiated, 
normal syngeneic spleen cells. After 7 d of incubation, the contents of 
each well were split into two aliquots, and their CTL activity was tested 
against both H 1 and H3 virus-infected target cells. The estimates were 
calculated as mentioned in the Materials and Methods. A/PR/8 (H 1N 1) 
and A/PC (H3N2) viruses were used to infect target cells in exp. 1 and 
2. In exp. 3, A/BZ (H1N1) and A/BK (H3N2) viruses were used. In 
exp. 4, A/BZ and A/X31 virus were used as H1N1 and H3N2, respec- 
tively. 
* 95% confidence limit. 
II and Fig. 1) reflected the recognition pattern of CTL precursors at a clonal 
level. 
Discussion 
In this paper, we have shown that an influenza virus-specific hybrid protein, 
made of the first 81 amino acids of NS1 and the HA2 subunit of viral HA, and 
produced in E. coli by recombinant DNA techniques, induced a secondary CTL 
response in vitro, and a memory CTL response in vivo. 
The observation that the entire HA, the HA2 alone, and the NS1 failed to 
induce the secondary CTL responses raised a question concerning which portion 
of the cl 3 protein, the NS1 and/or the HA2, contains the determinant respon- 
sible for inducing the CTL response. To address this question, we tested the 
ability of cl 3 protein-induced ffector cells to kill recombinant A/X31 (H3N2) 
virus-infected target cells, because all of the genome coding for the internal 
viral proteins of this virus was derived from the A/PR/8 parent virus, but the 
surface glycoproteins were derived from the parent H3N2 virus (26). The 
observation that c13 protein-induced effector cells were cytotoxic to A/PR/8 
virus-infected cells but not to A/X31 virus-infected target cells (Fig. 1 b) indi- 
cates that c 13 protein-induced H 1 subtype-specific CTL recognize the antigenic 
difference xpressed on the external glycoproteins. These results indicate that 
the HA2 portion of c l 3 protein has a determinant that is recognized by CTL 
precursors. 
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YAMADA ET AL. 671 
It has been reported that type A influenza virus-specific CTL generated in 
bulk culture show a broad specificity among type A viruses (2), while subtype- 
specific CTL have been also described (3, 10). The nature of the antigenic site(s) 
of the virus recognized by both subtype-specific and crossreactive CTL is still 
unclear. Recently, Braciale et al. (27) reported that influenza virus HA expressed 
on murine cells, using DNA-mediated gene transfer, was recognized by both 
subtype-specific CTL and a subset of crossreactive CTL. Although they did not 
show which subunit of HA was responsible for the recognition, it is conceivable 
that the important determinant for the subtype-specific recognition could be 
located on the HA2 subunit. They also showed that some crossreactive CTL 
clones failed to lyse HA-expressing target c lls, suggesting that viral product(s) 
other than HA might be recognized by crossreactive CTL. Kees and Krammer 
(28) reported that most of their short term CTL clones were specific for internal 
viral components, which appears to support this idea, even though the pattern 
of the crossreactivity was different from that of crossreactive CTL in bulk 
cultures, because those clones crossreacted among the viruses sharing genes 
coding for internal proteins. Furthermore, the isolation of CTL clones that react 
with internal proteins (14), and the observation that mouse L cells transfected 
with viral NP gene can serve as target cells to crossreactive CTL (29) also seem 
to provide evidence that the internal protein(s) are involved in the recognition 
by influenza virus-specific rossreactive CTL. 
The frequency of CTL precursors reacting with the subtype-specific determi- 
nant on HA2 is generally lower than that obtained by stimulation with virus- 
infected cells, although the CTL precursor frequencies varied between experi- 
ments. These results suggest that the majority of CTL precursors recognize viral 
determinant(s) other than those on HA2. 
The data presented in Table VI show that A/PR/8 virus-stimulated clones 
lysed both A/PR/8 virus- and A/PC virus-infected target cells. These observa- 
tions are different from those of Kees and Krammer (28), who reported that 
most CTL clones lysed only target cells which were infected with a virus that 
shared internal proteins with the virus used for elicitation of the response. The 
reason for this discrepancy is not clear; however, since they used spleen cells 
taken from mice 1 wk after the primary immunization, when the primary 
response to infection was beginning (1, 3), it is conceivable that the specificity 
pattern is different from that of spleen cells obtained from animals at least 3 wk 
after immunization. On the contrary, our results are in accordance with those of 
Owen et al. (30), who reported that ~80% of A/PR/8 virus-stimulated CTL 
clones lysed both A/PR/8 (H1N1) virus- and A/Northern Territory/60/68 
(H3N2) virus-infected cells. As the majority of CTL clones reactive with c13 
protein lysed only target cells infected with H 1 subtype viruses, it seems unlikely 
that fully crossreactive CTL precursors recognize conserved antigenic portions 
of the HA2 subunit. These results support the concept hat highly conserved 
internal proteins are recognized by these crossreactive CTL. 
Although we do not know the precise role of the first 81 amino acids of NS1, 
which is coupled to the HA2 in c13 protein, this region may be important for 
maintaining the tertiary structure of the protein, in order to present he immu- 
nodominant site to the responding cells, or for serving as an adjuvant. Since a 
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derivative of cl 3 protein (A13 protein) lacking 153 amino acids of the carboxy 
terminal end of the HA2 did not stimulate a CTL response, the antigenic site 
may be mapped to this portion; however, we could not rule out the possibility 
that the failure of A13 protein to induce CTL response may be due to the change 
of configuration because of the removal of this portion from c 13 protein. In this 
respect, it seems worth pointing out that a CNBr cleavage product of HA2 
(between residues 103 and 123) has been reported (12) to induce a subtype- 
specific secondary CTL response. The reason neither the entire HA nor HA2 
alone induced a CTL response is not clear. The lack of glycosylation of these 
proteins may be an explanation, although it is also possible that special factor(s) 
may be required for the generation of CTL response by these proteins, as 
described by Wabuke-Bunoti et al. (31). 
In conclusion, we have shown here that an influenza virus-specific hybrid 
protein including the first 81 amino acids of NS1 and the HA2 subunit of viral 
HA, prepared by recombinant DNA techniques, can produce both an in vitro 
secondary CTL response and in vivo generation of memory CTL in a subtype- 
specific manner. Since it has been reported (32) that a subtype-specific CTL 
clone can protect mice from lethal infection with influenza A virus, it will be 
interesting to see whether this protein induces protective immunity to the 
recipient mice. Experiments investigating this issue are now in progress. 
Summary 
We have tested the abilities of various polypeptides of A/PR/8/34 (H1N1) 
virus, constructed by recombinant DNA techniques, to induce influenza virus- 
specific secondary cytotoxic T lymphocyte (CTL) responses. A hybrid protein 
(cl 3 protein), consisting of the first 81 amino acids of viral nonstructural protein 
(NS 1) and the HA2 subunit of viral hemagglutinin (HA), induced H-2-restricted, 
influenza virus subtype-specific secondary CTL in vitro, although other peptides 
did not. Using a recombinant virus, the viral determinant responsible for rec- 
ognition was mapped to the HA2 portion of cl 3 protein. Immunization of mice 
with c13 protein induced the generation of memory CTL in vivo. The CTL 
precursor frequencies of A/PR/8/34 virus- and cl 3 protein-immune mice were 
estimated as one in 8,047 and 50,312, respectively. These results indicate that 
c 13 protein primed recipient mice, even though the level of precursor frequency 
was below that observed in virus-immune mice. 
Received for publication 25 March 1985. 
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